LUNDBECK LIMITED: UK Public Sector Contracts Won & Awards

SMEWatfordEast of EnglandMain market: Pharmaceutical products

Official UK PPONPHGC-5522-WLTL

Where they win

15 lot-level observations (6 awarded lots, 40%, plus 9 envelope awards without lot links; pending awards included) · top CPV classes

3360 Pharmaceutical products15 observations · 100% · 6 lots + 9 envelope
Attributable award value£299kSum of published VAT-exclusive values on 1 of 15 award records — only awards to this supplier alone, framework / DPS ceilings excluded; the award’s own value, else its contract’s; the five largest make 100%. Not turnover. Largest rows below.

Where they deliver

ITL1 delivery regions on the notice · 11 of 11 awarded procedures publish one · a procedure with several regions counts in each

Nationwide (UK)6 procedures · 55%
North East England2 procedures · 18%
North West England2 procedures · 18%
Yorkshire and the Humber2 procedures · 18%
East Midlands2 procedures · 18%
West Midlands2 procedures · 18%
East of England2 procedures · 18%
Greater London2 procedures · 18%

Bidding record

Procurement Act 2023 award notices name every bidder · 2 notices name this supplier since 26 Feb 2026 · observed bids, not an estimate

Contract contests0 won · 0 lostFewer than three decided contests — no rate is claimed.
Framework / DPS places2 of 2Admissions to a panel or dynamic market are counted apart: nearly every compliant bidder is appointed, so they say nothing about winning work.
Authorities bid for1
NoticeAuthorityOutcomeBiddersPublished
NHS National Generic Pharmaceuticals - Wave 16aframework/DPSNHS Englandappointed1251 Sept 2026
NHS National Generic Pharmaceuticals - Wave 15cframework/DPSNHS Englandappointed11826 Feb 2026

Source: bids.details[].tenderers on Procurement Act 2023 notices (from 2025). PCR 2015 notices name no bidders, so earlier contests are invisible here. Latest ten notices shown.

Who they sell to

Authorities named on this supplier’s published awards · ranked by distinct procedures · award records explode on framework and DPS panels

Authority type · official UK type when published, else name/id class, else not classified · by award records (a single panel can dominate)
  • NHS & health 80% (12 awards)
  • Central government 20% (3 awards)

Share = of the 11 procedures with an award naming this supplier. Last activity = award date, or notice publication when no award date was published.

Contracts ending

Published end dates only · 2 of 15 awards carry one · not a retender forecast

ContractEndsPublished value
Generic Drugs – Injections/Infusions 230 Jun 2027£5,841,104

Recent awards

Latest 15 of 15 award records naming this supplier

Data coverage & method
  • Source: Find a Tender OCDS award and contract releases. An award record is one award × this supplier; a procedure can carry many (panels, call-offs).
  • Market observations are awarded lots, or one envelope award when the notice publishes no lot links. Region = delivery ITL1 on the notice, not the supplier’s registered address.
  • Authority type: official OCDS UK contracting-authority type when the notice publishes one; otherwise a Tenderline name/id class; otherwise “not classified”. Purchasing hubs with no published type stay unclassified.
  • Published value attributable to this supplier alone: £299k across single-supplier awards, framework / DPS ceilings excluded. Coverage is partial and the figure is not turnover, so it is not shown as a headline.
  • Contract end dates: published on 2 of 15 awards; 1 end within 18 months.
  • Never shown: contact details, reliability or payment scores, affiliations, predicted wins.
Identifiers consolidated into this page (3 historical Find a Tender publication identifiers)

Official notices referenced this supplier under these publication identifiers. Alias URLs are not separate pages.

GB-FTS-120119GB-FTS-158200GB-FTS-40767

Canonical page id: GB-PPON:PHGC-5522-WLTL